Detailansicht

Wissensnetz

Person

Dietrich W. Beelen

Arzt

Name	Dietrich W. Beelen
Ort	Deutschland
Akademischer Grad bzw. Titel	Prof. Dr. med.
Beruf	Arzt (charakteristischer Beruf)
Variante	Dietrich Wilhelm Beelen (vollständiger Name)
Beziehung	Universitätsklinikum Essen (Klinik für Knochenmarktransplantation, Direktor)
Weitere Angaben	Mediziner, Psychologe, Direktor der Klinik für Knochenmarktransplantation
Quelle	Vorlage
Datensatztyp	Person
GND-Nummer	171970446
Datensatz-ID	171970446
Beteiligt an alle anzeigen Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients – A clinical trial to registry data comparison Data-driven grading of acute graft-versus-host disease Investigation of the impact of CMV reactivation and GVHD prophylaxis on alloreactivity after hematopoietic cell transplantation by data-driven analysis Treosulfan compared with reduced‐intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the ALWP of the EBMT A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation Biology-driven approaches to prevent and treat relapse of myeloid neoplasia after allogeneic hematopoietic stem cell transplantation Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation Allogeneic haematopoietic cell transplantation offers the chance of cure for patients with transformed follicular lymphoma Allogeneic stem cell transplantation for myelodysplastic syndrome patients with a 5q deletion Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects Bone marrow transplantation Bone marrow transplantation Knochenmarktransplantation Knochenmarktransplantation Einfluss von S-Adenosyl-Methionin auf die biliäre Ausscheidung von Bromsulphthalein, 14C-Glycocholsäure [C-Glycocholsäure] und endogenen Gallensäuren bei Ratten nach Chlorpromazin- und Anit-Vorbehandlung

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Dietrich W. Beelen

Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients – A clinical trial to registry data comparison

Data-driven grading of acute graft-versus-host disease

Investigation of the impact of CMV reactivation and GVHD prophylaxis on alloreactivity after hematopoietic cell transplantation by data-driven analysis

Treosulfan compared with reduced‐intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial

Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry

Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT

Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the ALWP of the EBMT

A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation

Biology-driven approaches to prevent and treat relapse of myeloid neoplasia after allogeneic hematopoietic stem cell transplantation

Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV

Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia

Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis

Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation

Allogeneic haematopoietic cell transplantation offers the chance of cure for patients with transformed follicular lymphoma

Allogeneic stem cell transplantation for myelodysplastic syndrome patients with a 5q deletion

Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects

Bone marrow transplantation

Bone marrow transplantation

Knochenmarktransplantation

Knochenmarktransplantation

Einfluss von S-Adenosyl-Methionin auf die biliäre Ausscheidung von Bromsulphthalein, 14C-Glycocholsäure [C-Glycocholsäure] und endogenen Gallensäuren bei Ratten nach Chlorpromazin- und Anit-Vorbehandlung